---
$id: https://graph.org.ai/products/commodity/51142502
$type: Product
source: UNSPSC
code: "51142502"
title: "Carbidopa"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbidopa

**UNSPSC Code**: 51142502
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C10H14N2O4.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MNX7R8C5VO, chemically known as hydrocinnamic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, l- but generally known as carbidopa, which bears US NIH Compound Identifier 2563. Carbidopa most often comes in base, anhydrous, and hydrate forms, and is often combined with Levodopa. European Medicines Agency schedules Carbidopa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06126MIG. CARBIDOPA is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carbidopa under HS 29280090 and SITC 51486. As of Q4 2014, CARBIDOPA remains the US FDA Preferred Term for this commodity. Carbidopa bears US NLM identifiers UMLS ID C0006982 and NCI Concept Code C47431. SMILES: CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.

